AMTZ participates at 2nd WRCB Industry Day

The Andhra Pradesh Medtech Zone (AMTZ) was among the medical and healthcare leaders who participated at the 2nd edition of the Wadhwani Research Centre for Bioengineering (WRCB) annual Industry Day that was held at IIT Bombay on Friday.

The event saw a gathering of eminent people including innovators, industry experts, entrepreneurs, researchers, medical practitioners and government representatives who are focused on converting a proof-of-concept to a marketable product.

Besides AMTZ, Eisai Pharmaceuticals, Pulse Pharmaceuticals, Indovasive, Biopore Surgicals, Sree Chitra Tirunal Institute of Medical Science and Technology, SRL Diagnostics, IIT Bombay were some of the other participants at the event.

Recent changes in regulatory framework in the field of biomedical device manufacturing were discussed during a panel discussion.

Notification on medical devices rules, correction to inverted duty structure, easing taxes on raw material import are the recent changes taken up by Government of India for the benefit of medical devices manufacturers.

Dr Jitendar Sharma, Director and CEO of AMTZ; Dr Jitendra Hegde, Managing Director, Indovasive; DS Nagesh, Head, Department of Technology and Quality Management, Biomedical Technology Wing, Sree Chitra Tirunal Institute of Medical Science and Technology; Satyaki Banerjee, CEO, Kiran Medical Systems; Professor B Ravi, Professor of Mechanical Engineering, Head ETFoundry and BETiC were among the panelists who provided their inputs on the need for regulatory frameworks to continuously evolve.

Andhra Pradesh MedTech Zone Limited (AMTZ), an enterprise under the Government of Andhra Pradesh dedicated for medical device and component manufacturers, has been setup as a one-stop solution for medical device manufacturing in India. The recent policy changes coupled with the world-class infrastructure being provided by AMTZ will act as a catalyst to drive local medical device manufacturing while making quality healthcare affordable and accessible.

Kalam Institute of Technology (KIHT), which will be housed within AMTZ, has been setup to facilitate smooth transitioning from proof-of-concept to commercialisation.

KIHT aims to facilitate focused research on critical components pertaining to medical devices by supporting institutions involved with R&D, industry, policy makers and knowledge repositories. KIHT will focus on technology transfer, innovation and market access, R&D support for industry, academia, research institutes and startups.


Follow and connect with us on

Related Health Business